Pombo Jiménez Marta, Cano Pérez Óscar, Chimeno García Javier, Bertomeu-González Vicente
Unidad de Estimulación, Agencia Pública Empresarial Sanitaria Costa del Sol, Marbella, Málaga, Spain.
Unidad de Electrofisiología y Arritmias, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Rev Esp Cardiol (Engl Ed). 2020 Dec;73(12):1038-1048. doi: 10.1016/j.rec.2020.09.010. Epub 2020 Oct 12.
This report describes Spanish cardiac pacing activity during 2019: quantities and types of devices and demographic and clinical factors.
The analysis is based on data obtained from the European Pacemaker Patient Identification Card, data submitted to the online platform cardiodispositivos.es, and supplier-reported data on the total number of implanted pacemakers.
Information was received on 15 833 procedures from 102 implantation centers, representing 39% of the estimated total activity. The implantation rates of conventional and resynchronization pacemakers were 832 and 32 units per million population, respectively. A total of 431 leadless pacemakers were implanted. Most implantations were performed in elderly patients (mean age, 78.7 years). Most electrodes were bipolar and with active fixation and 34.1% were magnetic resonance imaging-compatible. Atrioventricular block was the most common electrocardiographic abnormality. Dual-chamber sequential pacing predominated; nonetheless, up to 20% of patients in sinus rhythm received a single-chamber ventricular pacemaker, mainly those older than 80 years of age and women. Remote monitoring capability was present in 41% of cardiac resynchronization therapy pacemakers and in 14.8% of conventional pacemakers.
Consumption of pacing generators increased by 1.6%, mainly due to a 15.1% increase in cardiac resynchronization therapy pacemakers. Sequential pacing predominates; its use is influenced by age and sex. Remote monitoring increased by 20.6% in cardiac resynchronization therapy pacemakers and continues to be scarce in conventional pacemakers.
本报告描述了2019年西班牙心脏起搏活动情况:设备的数量和类型以及人口统计学和临床因素。
该分析基于从欧洲起搏器患者识别卡获得的数据、提交至在线平台cardiodispositivos.es的数据以及供应商报告的植入起搏器总数数据。
从102个植入中心收到了15833例手术的信息,占估计总活动量的39%。传统起搏器和再同步起搏器的植入率分别为每百万人口832台和32台。共植入了431台无导线起搏器。大多数植入手术是在老年患者(平均年龄78.7岁)中进行的。大多数电极是双极且主动固定的,34.1%与磁共振成像兼容。房室传导阻滞是最常见的心电图异常。双腔顺序起搏占主导;尽管如此,高达20%的窦性心律患者接受了单腔心室起搏器,主要是80岁以上的患者和女性。41%的心脏再同步治疗起搏器和14.8%的传统起搏器具备远程监测功能。
起搏发生器的消耗量增加了1.6%,主要是由于心脏再同步治疗起搏器增加了15.1%。顺序起搏占主导;其使用受年龄和性别的影响。心脏再同步治疗起搏器的远程监测增加了20.6%,而传统起搏器中仍然很少见。